| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $1,807,977 | 23 | 100 |
Sells | $0 | 0 | 0 |
| Siokas Grigorios | Chief Executive Officer | 22 | $1.76M | 0 | $0 | $1.76M |
| Terzis Georgios | Chief Financial Officer | 1 | $50,000 | 0 | $0 | $50,000 |
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Over the last 12 months, insiders at Cosmos Health Inc. have bought $1.81M and sold $0 worth of Cosmos Health Inc. stock.
On average, over the past 5 years, insiders at Cosmos Health Inc. have bought $3.46M and sold $682,752 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Siokas Grigorios (Chief Executive Officer) — $1.76M. Terzis Georgios (Chief Financial Officer) — $50,000.
The last purchase of 34,004 shares for transaction amount of $15,217 was made by Siokas Grigorios (Chief Executive Officer) on 2025‑05‑23.
| 2025-05-23 | Siokas Grigorios | Chief Executive Officer | 34,004 0.1183% | $0.45 | $15,217 | +5.08% | ||
| 2025-05-22 | Siokas Grigorios | Chief Executive Officer | 141,825 0.4933% | $0.44 | $62,800 | -2.15% | ||
| 2025-05-21 | Siokas Grigorios | Chief Executive Officer | 174,172 0.6058% | $0.47 | $82,000 | +2.79% | ||
| 2025-05-20 | Siokas Grigorios | Chief Executive Officer | 147,563 0.5132% | $0.45 | $65,961 | +4.64% | ||
| 2025-05-19 | Siokas Grigorios | Chief Executive Officer | 79,254 0.2757% | $0.43 | $34,000 | +7.89% | ||
| 2025-04-24 | Siokas Grigorios | Chief Executive Officer | 431,852 1.5851% | $0.40 | $173,000 | +9.56% | ||
| 2025-04-24 | Siokas Grigorios | Chief Executive Officer | 254,618 0.9346% | $0.40 | $102,000 | +9.56% | ||
| 2025-04-24 | Siokas Grigorios | Chief Executive Officer | 177,234 0.6505% | $0.40 | $71,000 | +9.56% | ||
| 2025-04-23 | Siokas Grigorios | Chief Executive Officer | 205,000 0.7513% | $0.40 | $82,000 | +9.70% | ||
| 2025-04-22 | Siokas Grigorios | Chief Executive Officer | 175,000 0.7851% | $0.36 | $63,000 | +21.57% | ||
| 2025-04-21 | Siokas Grigorios | Chief Executive Officer | 654,912 2.592% | $0.32 | $208,000 | +37.44% | ||
| 2025-03-04 | Siokas Grigorios | Chief Executive Officer | 85,714 0.3796% | $0.53 | $45,000 | -16.40% | ||
| 2025-03-03 | Siokas Grigorios | Chief Executive Officer | 132,572 0.5587% | $0.49 | $65,000 | -10.46% | ||
| 2025-02-24 | Siokas Grigorios | Chief Executive Officer | 354,296 1.3947% | $0.56 | $200,000 | -21.50% | ||
| 2025-01-30 | Siokas Grigorios | Chief Executive Officer | 51,414 0.2013% | $0.66 | $34,000 | -30.05% | ||
| 2025-01-22 | Siokas Grigorios | Chief Executive Officer | 38,900 0.1552% | $0.77 | $30,000 | -39.05% | ||
| 2025-01-17 | Siokas Grigorios | Chief Executive Officer | 29,158 0.1235% | $0.86 | $25,000 | -44.94% | ||
| 2025-01-16 | Siokas Grigorios | Chief Executive Officer | 47,904 0.2026% | $0.83 | $40,000 | -43.45% | ||
| 2025-01-15 | Siokas Grigorios | Chief Executive Officer | 62,500 0.281% | $0.80 | $50,000 | -40.91% | ||
| 2025-01-14 | Siokas Grigorios | Chief Executive Officer | 87,247 0.3827% | $0.69 | $60,000 | -31.22% |
| Siokas Grigorios | Chief Executive Officer | 6158884 21.062% | $2.66M | 41 | 36 | <0.0001% |
| Terzis Georgios | Chief Financial Officer | 727263 2.4871% | $314,323.07 | 1 | 0 | |
| MAVROGIANNIS VASILEIOS | 10 percent owner | 9700227 33.1726% | $4.19M | 2 | 8 | |
| DRAKOPOULOS PANAGIOTIS | CEO | 8758561 29.9523% | $3.79M | 0 | 7 | |
| GOLDSTEIN PETER | 157100 0.5372% | $67,898.62 | 1 | 0 |
$2,051,022 | 1591 | -12.84% | $80.19M | |
$22,899,264 | 81 | 34.90% | $20.39M | |
$218,350,131 | 64 | 16.68% | $218.02M | |
$125,860,243 | 57 | -4.48% | $32.12M | |
$2,740,482 | 50 | 9.37% | $29.05M | |
$30,209,812 | 45 | -1.91% | $12.5M | |
$3,140,759 | 30 | 10.79% | $15.22M | |
$423,174,478 | 29 | -7.58% | $27.36M | |
$17,389,773 | 25 | -6.03% | $294.46M | |
$25,034,841 | 20 | 9.38% | $113.08M | |
$934,616 | 12 | 74.76% | $7.47M | |
$758,061 | 9 | 60.03% | $147.93M | |
Cosmos Health Inc. (COSM) | $4,039,981 | 8 | -3.44% | $12.64M |
$8,171,353 | 7 | -14.29% | $12.16M | |
$11,881 | 4 | -32.05% | $9.99M | |
$103,523 | 3 | 9.40% | $63.13M | |
$999,999 | 1 | -52.42% | $16.2M | |
$5,003,136 | 1 | -14.58% | $248.44M | |
$10,000 | 1 | -96.58% | $6.72M |
| Increased Positions | 10 | +50% | 1M | +77.82% |
| Decreased Positions | 7 | -35% | 161,206 | -9.95% |
| New Positions | 5 | New | 90,043 | New |
| Sold Out Positions | 5 | Sold Out | 150,149 | Sold Out |
| Total Postitions | 23 | +15% | 3M | +67.88% |
| Armistice Capital, Llc | $337.00 | 2.77% | 748,826 | -910,024 | -54.86% | 2024-12-31 |
| Blackrock, Inc. | $121.00 | 0.99% | 267,797 | 0 | 0% | 2025-03-31 |
| Geode Capital Management, Llc | $87.00 | 0.72% | 193,432 | +43,704 | +29.19% | 2024-12-31 |
| Vanguard Group Inc | $61.00 | 0.5% | 134,834 | 0 | 0% | 2024-12-31 |
| Ubs Group Ag | $32.00 | 0.27% | 71,516 | -44,151 | -38.17% | 2024-12-31 |
| Susquehanna International Group, Llp | $19.00 | 0.16% | 42,272 | +42,272 | New | 2024-12-31 |
| Xtx Topco Ltd | $15.00 | 0.12% | 32,617 | +32,617 | New | 2024-12-31 |
| Virtu Financial Llc | $13.00 | 0.11% | 29,787 | +29,787 | New | 2024-12-31 |
| State Street Corp | $11.00 | 0.09% | 24,743 | 0 | 0% | 2024-12-31 |
| Two Sigma Securities, Llc | $11.00 | 0.09% | 23,544 | +9,162 | +63.7% | 2024-12-31 |